Radiolabeled RGD Tracer Kinetics Annotates Differential αvβ3 Integrin Expression Linked to Cell Intrinsic and Vessel Expression
- 474 Downloads
The purpose of this paper is to study the association between RGD binding kinetics and αvβ3 integrin receptor density in the complex tumor milieu.
We assessed αvβ3 in vitro and by 68Ga-DOTA-[c(RGDfK)]2 positron emission tomography (PET) in tumors with varying αvβ3.
Intrinsic αvβ3 expression decreased in the order of M21 >>> MDA-MB-231 > M21L in cells. Tumor volume of distribution by PET, V T, was significantly higher in M21 compared to isogenic M21L tumors (0.40 ± 0.01 versus 0.25 ± 0.02; p < 0.01) despite similar microvessel density (MVD) likely due to higher αvβ3. V T for MDA-MB-231 (0.40 ± 0.04) was comparable to M21 despite lower αvβ3 but in keeping with the higher MVD, suggesting superior tracer distribution.
This study demonstrates that radioligand binding kinetics of PET data can be used to discriminate tumors with different αvβ3 integrin expression—a key component of the angiogenesis phenotype—in vivo.
Key wordsIntegrin RGD peptide Positron emission tomography Kinetic modeling Vasculature
This work was funded by Cancer Research UK-Engineering and Physical Sciences Research Council grant C2536/A10337. E.O.A’s laboratory receives core funding from the UK Medical Research Council (MC US A652 0030).
Conflict of Interest
The authors declare no conflicts of interest.
- 15.Guo N, Lang L, Gao H, et al. (2012) Quantitative Analysis and Parametric Imaging of (18)F-Labeled Monomeric and Dimeric RGD Peptides Using Compartment Model. Mol Imaging Biol.Google Scholar
- 18.Witney TH, Kettunen MI, Day SE, et al. (2009) A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment. Neoplasia 11:574-582, 571 p following 582.Google Scholar